A detailed history of Modera Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Modera Wealth Management, LLC holds 24,801 shares of VRTX stock, worth $12 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
24,801
Previous 23,926 3.66%
Holding current value
$12 Million
Previous $9.74 Million 6.49%
% of portfolio
0.16%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $356,728 - $390,320
875 Added 3.66%
24,801 $10.4 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $406,112 - $486,245
1,184 Added 5.21%
23,926 $9.74 Million
Q3 2023

Nov 01, 2023

BUY
$338.18 - $362.46 $60,196 - $64,517
178 Added 0.79%
22,742 $7.91 Million
Q2 2023

Aug 07, 2023

BUY
$314.42 - $351.91 $7.09 Million - $7.94 Million
22,564 New
22,564 $7.94 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $124B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Modera Wealth Management, LLC Portfolio

Follow Modera Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Modera Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modera Wealth Management, LLC with notifications on news.